Valerio Celentano1, Mariano Cesare Giglio2, Luigi Bucci2. 1. Department of General, Oncologic and Video-Assisted Surgery, Colorectal Unit, Federico II University, Naples, Italy. valeriocelentano@yahoo.it. 2. Department of General, Oncologic and Video-Assisted Surgery, Colorectal Unit, Federico II University, Naples, Italy.
Abstract
BACKGROUND: Hartmann's reversal is a major surgical procedure with consistent morbidity and mortality rates. Laparoscopy has been extensively applied to colorectal surgery providing significant benefits on short- and long-term outcomes. We performed a meta-analysis of the current evidence comparing the short-term outcomes of laparoscopic Hartmann's reversal (LHR) to open Hartmann's reversal (OHR). METHODS: A systematic search of Medline, Scopus, Web of Science, Embase, and the Cochrane database was performed. Comparative studies reporting short-term outcomes of LHR versus OHR with an intention-to-treat analysis were considered for eligibility. Primary outcome was 30-day morbidity. Secondary outcomes were 30-day mortality, 30-day reoperations, length of hospital stay (LOS), operating time, and estimated blood loss. RESULTS: Thirteen studies comparing 862 patients (403 LHR vs 459 OHR) were included. There was no difference in mortality, while LHR was associated with a reduced overall postoperative 30-day morbidity (OR, 0.24; 95 % CI, 0.16 to 0.34). Wound infections (OR, 0.54; 95 % CI, 0.35 to 0.85) and ileus (OR, 0.47; 95 % CI, 0.25 to 0.87) were more common after OHR. LOS was shorter in the laparoscopic group as it was the time to flatus. Meta-regression analysis showed that the results were independent from potential effect modifiers. CONCLUSIONS: LHR has less short-term complications than OHR in terms of overall morbidity, wound infection, and postoperative ileus. LOS is shorter in the LHR group, while no significant difference exists in the operating time. Randomized controlled trials are needed to confirm these findings on unbiased populations.
BACKGROUND: Hartmann's reversal is a major surgical procedure with consistent morbidity and mortality rates. Laparoscopy has been extensively applied to colorectal surgery providing significant benefits on short- and long-term outcomes. We performed a meta-analysis of the current evidence comparing the short-term outcomes of laparoscopic Hartmann's reversal (LHR) to open Hartmann's reversal (OHR). METHODS: A systematic search of Medline, Scopus, Web of Science, Embase, and the Cochrane database was performed. Comparative studies reporting short-term outcomes of LHR versus OHR with an intention-to-treat analysis were considered for eligibility. Primary outcome was 30-day morbidity. Secondary outcomes were 30-day mortality, 30-day reoperations, length of hospital stay (LOS), operating time, and estimated blood loss. RESULTS: Thirteen studies comparing 862 patients (403 LHR vs 459 OHR) were included. There was no difference in mortality, while LHR was associated with a reduced overall postoperative 30-day morbidity (OR, 0.24; 95 % CI, 0.16 to 0.34). Wound infections (OR, 0.54; 95 % CI, 0.35 to 0.85) and ileus (OR, 0.47; 95 % CI, 0.25 to 0.87) were more common after OHR. LOS was shorter in the laparoscopic group as it was the time to flatus. Meta-regression analysis showed that the results were independent from potential effect modifiers. CONCLUSIONS: LHR has less short-term complications than OHR in terms of overall morbidity, wound infection, and postoperative ileus. LOS is shorter in the LHR group, while no significant difference exists in the operating time. Randomized controlled trials are needed to confirm these findings on unbiased populations.
Entities:
Keywords:
Hartmann’s procedure; Hartmann’s reversal; Laparoscopic colorectal surgery
Authors: Jeanine Arkenbosch; Hiromichi Miyagaki; H M C Shantha Kumara; Xiaohong Yan; Vesna Cekic; Richard L Whelan Journal: Surg Endosc Date: 2014-11-01 Impact factor: 4.584
Authors: Jean Pierre Faure; Carole Doucet; David Essique; Youssef Badra; Michel Carretier; Jean Pierre Richer; Michel Scépi Journal: Surg Laparosc Endosc Percutan Tech Date: 2007-12 Impact factor: 1.719
Authors: Francesco Guerra; Diego Coletta; Celeste Del Basso; Giuseppe Giuliani; Alberto Patriti Journal: World J Surg Date: 2019-07 Impact factor: 3.352
Authors: Jean-Sébastien Trépanier; María Clara Arroyave; Raquel Bravo; Marta Jiménez-Toscano; Francisco B DeLacy; María Fernandez-Hevia; Antonio M Lacy Journal: Surg Endosc Date: 2017-06-13 Impact factor: 4.584
Authors: F Ferrara; D Parini; A Bondurri; M Veltri; M Barbierato; F Pata; F Cattaneo; A Tafuri; C Forni; G Roveron; G Rizzo Journal: Tech Coloproctol Date: 2019-10-12 Impact factor: 3.781